(Q57757274)

1

0 references

Llovet

2

0 references

Efremidis

3

0 references

Shouval

4

0 references

Canelo

5

0 references

Ringe

6

0 references

Meyers

British Journal of Surgery

7

0 references

language of work or name

English

0 references

publication date

October 1998

0 references

published in

0 references

volume

85

0 references

issue

10

0 references

page(s)

1319-1331

0 references

cites work

NIH conference. Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Hepatocellular carcinoma: Recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Cirrhosis and the aetiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

HCV-associated liver cancer without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Workshop on Screening for Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Hepatocellular carcinoma in patients who undergo liver transplantation: sensitivity of CT with iodized oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Benign and malignant nodules in cirrhotic livers: distinction based on blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Contrast agents for MR imaging of the liver: a clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Impact of staging on the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Clinical trials in primary hepatocellular carcinoma: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Treatment of hepatocellular carcinoma: too many options?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Hormonal manipulation of human hepatocellular carcinoma. A clinical investigative and therapeutic opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Liver-spleen infarcts following transcatheter chemoembolization: a case report and review of the literature on adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Primary treatment of hepatocellular carcinoma by arterial chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Transcatheter oily chemoembolization of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Blood supply of early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Iodized oil in the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Hepatic resection versus transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection,

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.1998.00865.X